select a format

Single User License
USD 125 INR 8073
Site License
USD 250 INR 16145
Corporate User License
USD 375 INR 24218

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ... "Mohit Mittal, Consultant, KPMG Advisory Services"

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies.... "Mustafa Masood, Financial Analyst , Coldwell Banker Riyadh"

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"


Ajanta Pharma Ltd (AJANTPHARM)-Financial and Strategic SWOT Analysis Review

Ajanta Pharma Ltd (AJANTPHARM)-Financial and Strategic SWOT Analysis Review


  • Products Id :- GDPH114898FSA
  • |
  • Pages: 43
  • |
  • July 2017
  • |
  • |
  Request for Sample Report

Executive Summary

Ajanta Pharma Ltd (AJANTPHARM)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

Business description-A detailed description of the company operations and business divisions.

Corporate strategy-Analyst summarization of the company business strategy.

SWOT Analysis-A detailed analysis of the company strengths, weakness, opportunities and threats.

Company history-Progression of key events associated with the company.

Major products and services-A list of major products, services and brands of the company.

Key competitors-A list of key competitors to the company.

Key employees-A list of the key executives of the company.

Executive biographies-A brief summary of the executives' employment history.

Key operational heads-A list of personnel heading key departments/functions.

Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

Key manufacturing facilities-A list of key manufacturing facilities of the company.

Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Ajanta Pharma Ltd (Ajanta Pharma) is a specialty pharmaceutical company, which focuses on the research, manufacture and commercialization of finished dosages in domestic and international markets. The company has presence in cardiology, pain management, dermatology and ophthalmology. It provides generics in developed markets of USA and branded generics in emerging countries across India, Africa, CIS, Middle East and South East Asia. Ajanta Pharma also supplies multivitamins, eye drops, cough syrups and antibiotics to government bodies in India; and anti malarial products to Africa and Global Fund. The company operates seven manufacturing facilities and one research center. Ajanta Pharma is headquartered in Mumbai, Maharashtra, India.

Ajanta Pharma Ltd Key Recent Developments

Apr 10,2017: Ajanta Pharma Provides Update On US FDA Inspection At Dahej Formulation Facility

Feb 09,2017: Ajanta Pharma Provides Update On US FDA Inspection

Jan 24,2017: Ajanta Pharma Announces No import alert on us by US FDA

Jan 24,2017: Ajanta Pharma: PAT up 25%, Income from Operations up 12% in Q3 FY 2017

Oct 26,2016: Ajanta Pharma Reports Revenue Of INR5.16Billion In Q2 Fiscal 2017

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

The profile analyzes the company business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

The company core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
ankur [@] kenresearch.com
+91-9015378249
www.kenresearch.com

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Section 1-About the Company 5

Ajanta Pharma Ltd-Key Facts 5

Ajanta Pharma Ltd-Key Employees 6

Ajanta Pharma Ltd-Key Employee Biographies 7

Ajanta Pharma Ltd-Major Products and Services 8

Ajanta Pharma Ltd-History 9

Ajanta Pharma Ltd-Company Statement 11

Ajanta Pharma Ltd-Locations And Subsidiaries 12

Head Office 12

Other Locations & Subsidiaries 12

Section 2-Company Analysis 13

Ajanta Pharma Ltd-Business Description 13

Ajanta Pharma Ltd-Corporate Strategy 14

Ajanta Pharma Ltd-SWOT Analysis 15

SWOT Analysis-Overview 15

Ajanta Pharma Ltd-Strengths 15

Ajanta Pharma Ltd-Weaknesses 16

Ajanta Pharma Ltd-Opportunities 17

Ajanta Pharma Ltd-Threats 18

Ajanta Pharma Ltd-Key Competitors 19

Section 3-Company Financial Ratios 20

Financial Ratios-Capital Market Ratios 20

Financial Ratios-Annual Ratios 21

Performance Chart 24

Financial Performance 24

Financial Ratios-Interim Ratios 25

Financial Ratios-Ratio Charts 26

Section 4-Company's Lifesciences Financial Deals and Alliances 27

Ajanta Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 27

Ajanta Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 28

Ajanta Pharma Ltd, Recent Deals Summary 29

Section 5-Company's Recent Developments 30

Apr 10, 2017: Ajanta Pharma Provides Update On US FDA Inspection At Dahej Formulation Facility 30

Feb 09, 2017: Ajanta Pharma Provides Update On US FDA Inspection 31

Jan 24, 2017: Ajanta Pharma Announces No import alert on us by US FDA 32

Jan 24, 2017: Ajanta Pharma: PAT up 25%, Income from Operations up 12% in Q3 FY 2017 33

Oct 26, 2016: Ajanta Pharma Reports Revenue Of INR5.16Billion In Q2 Fiscal 2017 35

Jul 26, 2016: Ajanta Pharma: PAT up 39%, Operating Revenue up 20% 36

Apr 29, 2016: Ajanta Pharma : Q4 FY 2016 PAT up 43%, Operating Revenue up 14% 37

Section 6-Appendix 39

Methodology 39

Ratio Definitions 39

About GlobalData 43

Contact Us 43

Disclaimer 43

List of Figures

Ajanta Pharma Ltd, Performance Chart (2013-2017) 24

Ajanta Pharma Ltd, Ratio Charts 26

Ajanta Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 27

Ajanta Pharma Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 28

List of Tables

Ajanta Pharma Ltd, Key Facts 5

Ajanta Pharma Ltd, Key Employees 6

Ajanta Pharma Ltd, Key Employee Biographies 7

Ajanta Pharma Ltd, Major Products and Services 8

Ajanta Pharma Ltd, History 9

Ajanta Pharma Ltd, Subsidiaries 12

Ajanta Pharma Ltd, Key Competitors 19

Ajanta Pharma Ltd, Ratios based on current share price 20

Ajanta Pharma Ltd, Annual Ratios 21

Ajanta Pharma Ltd, Annual Ratios (Cont...1) 22

Ajanta Pharma Ltd, Annual Ratios (Cont...2) 23

Ajanta Pharma Ltd, Interim Ratios 25

Ajanta Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 27

Ajanta Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 28

Ajanta Pharma Ltd, Recent Deals Summary 29

Currency Codes 39

Capital Market Ratios 39

Equity Ratios 40

Profitability Ratios 40

Cost Ratios 41

Liquidity Ratios 41

Leverage Ratios 42

Efficiency Ratios 42

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 


Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com